CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - Management
What follow-up arrangement should I consider for a woman using the combined contraceptive patch?
- Review the woman no longer than 3 months after she starts to use the contraceptive patch, to ensure correct use and that there are no problems.
- Depending on the woman's wishes and anticipated use of the patch, arrange for up to 1 year's supply following this, before requiring a new prescription. Women with specific medical conditions may need more frequent follow-up.
- Advise the woman that she should return at any time if she has any problems.
Basis for recommendation
- These recommendations are pragmatic and are based on those issued for combined oral contraceptives, because both formulations are combined hormonal contraceptives — see Follow-up.
- The contraceptive patch's current status as a Black Triangle drug is an additional reason to review the woman no longer than 3 months after she starts to use it.
© NHS Institute for Innovation and Improvement